248 related articles for article (PubMed ID: 19640893)
21. Predictors for treatment failure after laparoscopic electrocautery of the ovaries in women with clomiphene citrate resistant polycystic ovary syndrome.
van Wely M; Bayram N; van der Veen F; Bossuyt PM
Hum Reprod; 2005 Apr; 20(4):900-5. PubMed ID: 15640254
[TBL] [Abstract][Full Text] [Related]
22. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
23. Hormone profiles and clinical outcome after laparoscopic ovarian drilling in women with polycystic ovary syndrome.
Kucuk M; Kilic-Okman T
Med Sci Monit; 2005 Jan; 11(1):CR29-34. PubMed ID: 15614192
[TBL] [Abstract][Full Text] [Related]
24. Anti-mullerian hormone as a predictive factor in assisted reproductive technique of polycystic ovary syndrome patients.
Aleyasin A; Aghahoseini M; Mokhtar S; Fallahi P
Acta Med Iran; 2011; 49(11):715-20. PubMed ID: 22131240
[TBL] [Abstract][Full Text] [Related]
25. Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome.
Palomba S; Orio F; Falbo A; Russo T; Caterina G; Manguso F; Tolino A; Colao A; Zullo F
Clin Endocrinol (Oxf); 2005 Dec; 63(6):631-5. PubMed ID: 16343096
[TBL] [Abstract][Full Text] [Related]
26. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of laparoscopic ovarian drilling for polycystic ovary syndrome resistant to clomiphene citrate.
Kato M; Kikuchi I; Shimaniki H; Kobori H; Aida T; Kitade M; Kumakiri J; Takeuchi H
J Obstet Gynaecol Res; 2007 Apr; 33(2):174-80. PubMed ID: 17441891
[TBL] [Abstract][Full Text] [Related]
28. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.
Nardo LG; Yates AP; Roberts SA; Pemberton P; Laing I
Hum Reprod; 2009 Nov; 24(11):2917-23. PubMed ID: 19617605
[TBL] [Abstract][Full Text] [Related]
29. The effect of laparoscopic ovarian drilling in patients with anovulatory polycystic ovary syndrome and high serum levels of anti-Müllerian hormone.
Mohammad SM
J Med Life; 2023 Jul; 16(7):1047-1049. PubMed ID: 37900074
[TBL] [Abstract][Full Text] [Related]
30. The impact of laparoscopic ovarian drilling on AMH and ovarian reserve: a meta-analysis.
Amer SA; Shamy TTE; James C; Yosef AH; Mohamed AA
Reproduction; 2017 Jul; 154(1):R13-R21. PubMed ID: 28420801
[TBL] [Abstract][Full Text] [Related]
31. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.
Laven JS; Mulders AG; Visser JA; Themmen AP; De Jong FH; Fauser BC
J Clin Endocrinol Metab; 2004 Jan; 89(1):318-23. PubMed ID: 14715867
[TBL] [Abstract][Full Text] [Related]
32. Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome.
Saleh AM; Khalil HS
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):614-21. PubMed ID: 15225184
[TBL] [Abstract][Full Text] [Related]
33. Müllerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome.
Wang JG; Nakhuda GS; Guarnaccia MM; Sauer MV; Lobo RA
Am J Obstet Gynecol; 2007 Jan; 196(1):77.e1-5. PubMed ID: 17240243
[TBL] [Abstract][Full Text] [Related]
34. Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome.
Catteau-Jonard S; Pigny P; Reyss AC; Decanter C; Poncelet E; Dewailly D
J Clin Endocrinol Metab; 2007 Nov; 92(11):4138-43. PubMed ID: 17698904
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of serum concentration of anti-Müllerian hormone in obese women with polycystic ovary syndrome.
El-Halawaty S; Rizk A; Kamal M; Aboulhassan M; Al-Sawah H; Noah O; Al-Inany H
Reprod Biomed Online; 2007 Nov; 15(5):495-9. PubMed ID: 18028738
[TBL] [Abstract][Full Text] [Related]
36. Ovarian reserve in women with polycystic ovary syndrome who underwent laparoscopic ovarian drilling.
Weerakiet S; Lertvikool S; Tingthanatikul Y; Wansumrith S; Leelaphiwat S; Jultanmas R
Gynecol Endocrinol; 2007; 23(8):455-60. PubMed ID: 17852413
[TBL] [Abstract][Full Text] [Related]
37. Laparoscopic ovarian drilling in polycystic ovary syndrome.
Api M; Görgen H; Cetin A
Eur J Obstet Gynecol Reprod Biol; 2005 Mar; 119(1):76-81. PubMed ID: 15734089
[TBL] [Abstract][Full Text] [Related]
38. Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Piouka A; Livadas S; Piperi C; Katsikis I; Papavassiliou AG; Panidis D
Eur J Endocrinol; 2009 May; 160(5):847-53. PubMed ID: 19208775
[TBL] [Abstract][Full Text] [Related]
39. The influence of circulating anti-Müllerian hormone on ovarian responsiveness to ovulation induction with gonadotrophins in women with polycystic ovarian syndrome: a pilot study.
Amer SA; Mahran A; Abdelmaged A; El-Adawy AR; Eissa MK; Shaw RW
Reprod Biol Endocrinol; 2013 Dec; 11():115. PubMed ID: 24341292
[TBL] [Abstract][Full Text] [Related]
40. Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome.
Sahmay S; Atakul N; Oncul M; Tuten A; Aydogan B; Seyisoglu H
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):157-61. PubMed ID: 23806449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
